BackRXR Acquisition - Warrants (01/01/2025) Overview

RXR Acquisition - Warrants (01/01/2025) Total Liabilities

Track RXR Acquisition - Warrants (01/01/2025)'s total liabilities ($13M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$13.42M

Peer average

Loading

RXR Acquisition - Warrants (01/01/2025) Total Liabilities History

Loading

RXR Acquisition - Warrants (01/01/2025) vs. peers: Total Liabilities Comparison

Loading

RXR Acquisition - Warrants (01/01/2025) Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

RXR Acquisition - Warrants (01/01/2025) (RXRAW) FAQ

The latest total liabilities for RXRAW is $13M as of September 2022. In the prior-year period, the figure was $0. Investors often review this figure alongside RXR Acquisition - Warrants (01/01/2025)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, RXRAW's total liabilities moved from $0 to $13M. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in RXR Acquisition - Warrants (01/01/2025)'s operating scale or balance-sheet position.

A total liabilities figure of $13M for RXRAW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting RXRAW's total liabilities ($13M), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.